A specialist investor which aims to found and build companies in areas of 'critical' health.
CHARGE PER TRADE
Prices as at 04 Dec 2023.
Fund commentary last updated 29 Nov 2022.
Past performance is not an indication of future performance.
Capital at risk.
|Sector||Biotechnology & Healthcare|
|Dividends paid||June, July, August|
|Annual Management Charge||1.05%|
|Ongoing Charges Figure||1.14%|
The information on this website is not intended to be advice or a recommendation to buy, sell or hold any investment mentioned. The value of investments and the income from them can go down as well as up and you may not get back the amount invested.
Past performance is not a guide to future performance. View full risk warning